Overview

Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to assess the safety of the etonogestrel-releasing subdermal implant (Implanon) inserted during the immediate puerperium of healthy women.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Desogestrel
Etonogestrel
Medroxyprogesterone
Medroxyprogesterone Acetate